TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ocumension Therapeutics ( (HK:1477) ) just unveiled an announcement.
Ocumension Therapeutics announced that all resolutions proposed at their Annual General Meeting on June 19, 2025, were passed as ordinary resolutions. Key resolutions included the re-election of directors, the re-appointment of auditors, and the authorization for the board to manage shares, reflecting strong shareholder support and potentially enhancing the company’s governance and operational capabilities.
The most recent analyst rating on (HK:1477) stock is a Buy with a HK$7.29 price target. To see the full list of analyst forecasts on Ocumension Therapeutics stock, see the HK:1477 Stock Forecast page.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, primarily involved in the healthcare sector with a focus on therapeutic solutions.
Average Trading Volume: 6,700,567
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.29B
For detailed information about 1477 stock, go to TipRanks’ Stock Analysis page.